Medical Condition News

RSS

Are newer prostate cancer treatments — now gaining popularity — worth the extra cost?

Newer technologies for treating prostate cancer have surged in popularity in the last decade — and they have come with a hefty price tag, according to a report published this week.

19 Mar 2011

Celebrity Chefs Cook Gala to support cancer research at UC San Diego

Top celebrity chefs from around the country will gather in San Diego April 16 for the 30th Celebrity Chefs Cook Gala benefiting research at the UC San Diego Moores Cancer Center. Themed "Epicurean Elegance: Food for the Mind, Body and Spirit," the gala will feature lush food artistry as 11 premiere chefs prepare their signature hors d'oeuvres paired with fine wine. Proceeds from the event will support the cancer center's most urgent needs.

19 Mar 2011

ACRIN, ECOG, NCI intent to merge their clinical cancer research programs

The American College of Radiology's Imaging Network and the Eastern Cooperative Oncology Group, National Cancer Institute Clinical Trials Cooperative Group members, today announced their intent to merge their clinical cancer research programs.

19 Mar 2011

BioMarin announces preliminary results from ADAPT in patients suffering from PKU

BioMarin Pharmaceutical Inc. announced today preliminary results from ADAPT (A Diversified Approach for PKU Treatment) in an abstract (Abstract #91, Mental Health Screening in Phenylketoniuria Clinic) presented by Barbara Burton, MD at the 2011 annual American College of Medical Genetics conference in Vancouver, Canada.

19 Mar 2011

The Lancet publishes Oceana's Solesta injectable gel study results against fecal incontinence

Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced the publication of results from a randomized-controlled clinical trial of the bulking agent, NASHA DX, a dextranomer suspended in stabilized, which was injected into the submucosa of the anal canal in patients with fecal incontinence.

19 Mar 2011

Patient society representatives gather to discuss new strategies to fight osteoporosis

Today, more than 130 osteoporosis patient society representatives gathered in Valencia, Spain for the opening of the 13th IOF World Wide Conference of Osteoporosis Patient Societies.

19 Mar 2011

Researchers develop new system that documents healing process in detail

Knee patients need patience: injuries to these joints take weeks to heal. Fraunhofer researchers have now developed a system that documents the healing process in detail. This motivates patients and at the same time helps doctors to fine-tune the course of treatment.

19 Mar 2011

Experts issue joint statement to help Americans understand radiation-related health risks

The growing concern surrounding the release of radiation from an earthquake and tsunami-stricken nuclear complex in Japan has raised fears of radiation exposure to populations in North America from the potential plume of radioactivity crossing the Pacific Ocean.

19 Mar 2011

Researchers review patient outcomes from full, partial organ removal for kidney cancer

Patients with kidney cancer who had their entire organ removed were more likely to have more renal complications and poorer health after surgery, compared to those who had only part of their kidney removed, a study has shown.

19 Mar 2011

Quark Pharmaceuticals receives results from Phase 2 trial of PF-04523655 in patients with DME

Quark Pharmaceuticals, Inc., a pharmaceutical company engaged in the discovery and development of RNAi-based therapeutics, today announced that it has received results from a prospective randomized Phase 2 trial, the DEGAS study.

19 Mar 2011

Deaths from heart attacks drop precipitously in Norway, reports NTNU researcher

Life was hard in occupied Norway during WWII, but the occupation had one surprising result: deaths from heart attacks dropped precipitously, because Norwegians ate less fat, smoked less and were more physically active.

19 Mar 2011

Journal of Clinical Lipidology publishes LipoScience LDL particle study results against CVD

LipoScience, Inc., a highly innovative diagnostic company that is advancing patient care by developing high value proprietary blood tests using nuclear magnetic resonance technology, today announced publication of a clinical study in the Journal of Clinical Lipidology demonstrating that in many people, low density lipoprotein cholesterol is a less accurate predictor of cardiovascular disease events than LDL particle number.

19 Mar 2011

Removal of menthol cigarettes from marketplace would benefit public health in US: FDA

Finding that the availability of menthol cigarettes increases the number of children and African Americans who smoke, the Food and Drug Administration's Tobacco Products Scientific Advisory Committee today concluded, "Removal of menthol cigarettes from the marketplace would benefit public health in the United States."

19 Mar 2011

New insight into Duchenne muscular dystrophy

Armed with a zebrafish model of Duchenne muscular dystrophy and a library of 1,200 chemicals already approved for human use, researchers at Children's Hospital Boston have identified a compound that reverses the loss of muscle structure and function associated with DMD, seemingly by compensating for the loss of a critical protein.

19 Mar 2011

Cognitive impairment may not be fully reversible in patients with liver disease: Study

There are potential legal ramifications for physicians of patients who drive with cognitive impairment, according to a study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association Institute.

19 Mar 2011

Scientists discover enzyme family that plays a crucial role in regulating cell motility

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered that members of an enzyme family found in humans and throughout the plant and animal kingdoms play a crucial role in regulating cell motility. Their findings suggest an entirely new strategy for treating conditions ranging from diabetic ulcers to metastatic cancer.

19 Mar 2011

Springer editor receives ERC Advanced Grants for biosilicate research

The European Research Council has awarded one of this year's ERC Advanced Grants to Springer editor Dr. Werner M-ller, thus supporting his well-established research in the field of biosilicates with prize money of 2.2 million euros.

19 Mar 2011

OGRRGA offers new service for women with PPD

Obstetricians & Gynecologists RRG of America, Inc., an insurance company for ob/gyns, announced today a new service for women who have delivered. Via http://www.freeppdtest.com the company offers a free postpartum depression signup for doctors and their patients. The Company believes it is the first such offer in America.

19 Mar 2011

Oncologists to discuss treatment of blood cancer in elderly

Top oncologists are meeting in Rome today to discuss the treatment of blood cancer in the elderly, with the aim of driving widespread change to ensure equality of care for everyone, whatever their chronological age.

19 Mar 2011

Polaris initiates ADI-PEG 20 Phase 2 trial in patients with malignant mesothelioma

Polaris Group announced today the enrollment of the first patient in a Phase 2 clinical trial of ADI-PEG 20, the company's novel enzyme-based treatment for malignant mesothelioma.

19 Mar 2011

Medical Condition News

Are newer prostate cancer treatments — now gaining popularity — worth the extra cost?

Celebrity Chefs Cook Gala to support cancer research at UC San Diego

ACRIN, ECOG, NCI intent to merge their clinical cancer research programs

BioMarin announces preliminary results from ADAPT in patients suffering from PKU

The Lancet publishes Oceana's Solesta injectable gel study results against fecal incontinence

Patient society representatives gather to discuss new strategies to fight osteoporosis

Researchers develop new system that documents healing process in detail

Experts issue joint statement to help Americans understand radiation-related health risks

Researchers review patient outcomes from full, partial organ removal for kidney cancer

Quark Pharmaceuticals receives results from Phase 2 trial of PF-04523655 in patients with DME

Deaths from heart attacks drop precipitously in Norway, reports NTNU researcher

Journal of Clinical Lipidology publishes LipoScience LDL particle study results against CVD

Removal of menthol cigarettes from marketplace would benefit public health in US: FDA

New insight into Duchenne muscular dystrophy

Cognitive impairment may not be fully reversible in patients with liver disease: Study

Scientists discover enzyme family that plays a crucial role in regulating cell motility

Springer editor receives ERC Advanced Grants for biosilicate research

OGRRGA offers new service for women with PPD

Oncologists to discuss treatment of blood cancer in elderly

Polaris initiates ADI-PEG 20 Phase 2 trial in patients with malignant mesothelioma

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News